FAST vs KAPA · P/E 43, rev $4.59B vs $18.8M cap
Fastenal Company (FAST) versus Kairos Pharma, Ltd. (KAPA) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Kairos Pharma, Ltd. (KAPA) is a biotechnology company listed on US.
Latest reported FAST revenue for 2026-06-30 was $4.59B. Net income was $722.6M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
KAPA does not have a complete income-statement cache yet.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. KAPA currently screens at market cap $18.8M.
Not investment advice. Open the FAST and KAPA stock pages for the full models.
Not investment advice.